Glycogen storage disease type II differential diagnosis: Difference between revisions
No edit summary |
No edit summary |
||
Line 35: | Line 35: | ||
!Cardiomegaly | !Cardiomegaly | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Glycogen storage disease type II | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Glycogen storage disease type II''' | ||
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki> | | style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki> | ||
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki> | | style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki> | ||
Line 47: | Line 47: | ||
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki> | | style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki> | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Glycogen storage disease type III | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Glycogen storage disease type III''' | ||
| style="background: #F5F5F5; padding: 5px;" | - | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki> | | style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki> | ||
Line 59: | Line 59: | ||
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki> | | style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki> | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Glycogen storage disease type IV | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Glycogen storage disease type IV''' | ||
| style="background: #F5F5F5; padding: 5px;" | - | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki> | | style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki> | ||
Line 71: | Line 71: | ||
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki> | | style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki> | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Acute Werdnig-Hoffmann disease (spinal muscular atrophy) | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Acute Werdnig-Hoffmann disease (spinal muscular atrophy)''' | ||
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki> | | style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki> | ||
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki> | | style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki> | ||
Line 83: | Line 83: | ||
| style="background: #F5F5F5; padding: 5px;" | - | | style="background: #F5F5F5; padding: 5px;" | - | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Hypothyroidism | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Hypothyroidism''' | ||
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki> | | style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki> | ||
| style="background: #F5F5F5; padding: 5px;" | - | | style="background: #F5F5F5; padding: 5px;" | - | ||
Line 95: | Line 95: | ||
| style="background: #F5F5F5; padding: 5px;" | - | | style="background: #F5F5F5; padding: 5px;" | - | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Endocardial fibroelastosis | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Endocardial fibroelastosis''' | ||
| style="background: #F5F5F5; padding: 5px;" | - | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | - | | style="background: #F5F5F5; padding: 5px;" | - | ||
Line 107: | Line 107: | ||
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki> | | style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki> | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Myocarditis | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Myocarditis''' | ||
| style="background: #F5F5F5; padding: 5px;" | - | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | - | | style="background: #F5F5F5; padding: 5px;" | - | ||
Line 119: | Line 119: | ||
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki> | | style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki> | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Congenital muscular dystrophy | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Congenital muscular dystrophy''' | ||
| style="background: #F5F5F5; padding: 5px;" | ++ | | style="background: #F5F5F5; padding: 5px;" | ++ | ||
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki> | | style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki> | ||
Line 131: | Line 131: | ||
| style="background: #F5F5F5; padding: 5px;" | - | | style="background: #F5F5F5; padding: 5px;" | - | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Mitochondrial/respiratory chain disorder | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Mitochondrial/respiratory chain disorder''' | ||
| style="background: #F5F5F5; padding: 5px;" | - | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki> | | style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki> | ||
Line 143: | Line 143: | ||
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki> | | style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki> | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Peroxisomal disorders | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Peroxisomal disorders''' | ||
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki> | | style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki> | ||
| style="background: #F5F5F5; padding: 5px;" | - | | style="background: #F5F5F5; padding: 5px;" | - | ||
Line 155: | Line 155: | ||
| style="background: #F5F5F5; padding: 5px;" | - | | style="background: #F5F5F5; padding: 5px;" | - | ||
|} | |} | ||
=== Table Differentiating Late Onset Glycogen Storage Disease Type II from other Diseases === | |||
==References== | ==References== |
Revision as of 18:01, 22 January 2018
Glycogen storage disease type II Microchapters |
Differentiating Glycogen storage disease type II from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Glycogen storage disease type II differential diagnosis On the Web |
American Roentgen Ray Society Images of Glycogen storage disease type II differential diagnosis |
FDA on Glycogen storage disease type II differential diagnosis |
CDC on Glycogen storage disease type II differential diagnosis |
Glycogen storage disease type II differential diagnosis in the news |
Blogs on Glycogen storage disease type II differential diagnosis |
Directions to Hospitals Treating Glycogen storage disease type II |
Risk calculators and risk factors for Glycogen storage disease type II differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
[Disease name] must be differentiated from other diseases that cause [clinical feature 1], [clinical feature 2], and [clinical feature 3], such as [differential dx1], [differential dx2], and [differential dx3].
OR
[Disease name] must be differentiated from [[differential dx1], [differential dx2], and [differential dx3].
Differentiating Infantile Onset Glycogen Storage Disease Type II from other Diseases
- [Disease name] must be differentiated from other diseases that cause [clinical feature 1], [clinical feature 2], and [clinical feature 3], such as [differential dx1], [differential dx2], and [differential dx3].
- [Disease name] must be differentiated from [[differential dx1], [differential dx2], and [differential dx3].
- As [disease name] manifests in a variety of clinical forms, differentiation must be established in accordance with the particular subtype. [Subtype name 1] must be differentiated from other diseases that cause [clinical feature 1], such as [differential dx1] and [differential dx2]. In contrast, [subtype name 2] must be differentiated from other diseases that cause [clinical feature 2], such as [differential dx3] and [differential dx4].
Table Differentiating Infantile Onset Glycogen Storage Disease Type II from other Diseases
Diseases | History and Symptoms | Physical Examination | Laboratory Findings | Imaging findings | ||||||
---|---|---|---|---|---|---|---|---|---|---|
Hypotonia | Myopathy | Dyspnea | Feeding difficulties | Absent reflex | Macroglossia | Hepatomegaly | Heart failure | Elevated CK | Cardiomegaly | |
Glycogen storage disease type II | + | + | + | + | + | + | + | + | + | + |
Glycogen storage disease type III | - | + | - | - | - | - | + | - | + | + |
Glycogen storage disease type IV | - | + | - | - | - | - | + | - | + | + |
Acute Werdnig-Hoffmann disease (spinal muscular atrophy) | + | + | - | - | + | - | - | - | - | - |
Hypothyroidism | + | - | - | - | - | + | - | - | - | - |
Endocardial fibroelastosis | - | - | + | + | - | - | - | + | - | + |
Myocarditis | - | - | - | - | - | - | - | - | - | + |
Congenital muscular dystrophy | ++ | + | - | - | - | - | - | - | - | - |
Mitochondrial/respiratory chain disorder | - | + | - | - | - | - | + | - | + | + |
Peroxisomal disorders | + | - | - | - | - | - | + | - | - | - |